Normal Perinatal Rise in Serum Cholesterol Is Inhibited by Hepatic Delivery of Adenoviral Vector Expressing Apolipoprotein B mRNA Editing Enzyme (Apobec1) in Rabbits
- 31 July 1999
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 85 (1), 148-157
- https://doi.org/10.1006/jsre.1999.5654
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Characterization of the Immune Response After Local Delivery of Recombinant Adenovirus in Murine Pancreas and Successful Strategies for ReadministrationHuman Gene Therapy, 1997
- Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liverProceedings of the National Academy of Sciences, 1997
- Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors.Journal of Clinical Investigation, 1997
- Adenoviruses as Gene-Delivery VehiclesNew England Journal of Medicine, 1996
- Immune responses to transgene–encoded proteins limit the stability of gene expression after injection of replication–defective adenovirus vectorsNature Medicine, 1996
- Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus–mediated transfer of the VLDL receptor geneNature Genetics, 1996
- Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.Proceedings of the National Academy of Sciences, 1995
- Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.Proceedings of the National Academy of Sciences, 1994
- Adenovirus mediated expression of therapeutic plasma levels of human factor IX in miceNature Genetics, 1993
- In utero transplantation of hematopoietic stem cellsCritical Reviews in Oncology/Hematology, 1993